{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T10:00:03Z","timestamp":1710928803069},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":264,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2001,4]]},"abstract":"<jats:p><jats:bold>Background<\/jats:bold> Knowledge about the possible role of phospholipase C (PLC) activity of microbial pathogens in the development of disease is increasing. Recently attention has focused on investigating PLC activity elaborated by <jats:italic>Helicobacter pylori<\/jats:italic>, but the role of this enzyme in <jats:italic>H. pylori<\/jats:italic> pathogenesis is still unknown. The aim of this study was to correlate PLC\u2010activity of <jats:italic>H. pylori<\/jats:italic> on the basis of the <jats:italic>cagA<\/jats:italic> status with the clinical diagnosis of the patients.<\/jats:p><jats:p><jats:bold>Materials and methods<\/jats:bold>  <jats:italic>Helicobacter pylori<\/jats:italic> was isolated from patients with gastritis (G; <jats:italic>n<\/jats:italic>\u2003=\u200338), duodenal ulcer (DU; <jats:italic>n<\/jats:italic>\u2003=\u200315), gastric ulcer (GU; <jats:italic>n<\/jats:italic>\u2003=\u200311) and gastric cancer (GC; <jats:italic>n<\/jats:italic>\u2003=\u200312). Polymerase chain reaction primers DZ3\/R009 which amplified a 1350\u2010bp fragment were used to detect the <jats:italic>cagA<\/jats:italic> gene. PLC activity was determined using <jats:italic>p<\/jats:italic>\u2010nitrophenylphosphorylcholine as substrate.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> Of the strains, 60% were <jats:italic>cagA<\/jats:italic><jats:sup><jats:italic>+<\/jats:italic><\/jats:sup> and 40% were <jats:italic>cagA<\/jats:italic><jats:sup>\u2212<\/jats:sup>. All strains showed PLC activity (2\u00b720\u2003\u00b1\u20030\u00b791\u2003U\u2003mg<jats:sup>\u22121<\/jats:sup> protein). PLC activity showed no association with the <jats:italic>cagA<\/jats:italic> status: <jats:italic>cagA<\/jats:italic><jats:sup><jats:italic>+<\/jats:italic><\/jats:sup> (2\u00b721\u2003\u00b1\u20031\u00b703\u2003U\u2003mg<jats:sup>\u22121<\/jats:sup> protein), <jats:italic>cagA<\/jats:italic><jats:sup>\u2212<\/jats:sup> (2\u00b718\u2003\u00b1\u20030\u00b779\u2003U\u2003mg<jats:sup>\u22121<\/jats:sup> protein). Patients with GU had the highest PLC activity (2\u00b777\u2003\u00b1\u20031\u00b726\u2003U\u2003mg<jats:sup>\u22121<\/jats:sup> protein) and patients with GC had the lowest activity (1\u00b78\u2003\u00b1\u20030\u00b757\u2003U\u2003mg<jats:sup>\u22121<\/jats:sup> protein).<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> Although PLC activity was present in all strains tested, it may only have pathological importance in patients with GU. However, the extent of PLC activity was independent of the presence of the <jats:italic>cagA<\/jats:italic> gene.<\/jats:p>","DOI":"10.1046\/j.1365-2362.2001.00814.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T15:51:55Z","timestamp":1047397915000},"page":"344-348","source":"Crossref","is-referenced-by-count":5,"title":["Phospholipase C activity of <i>Helicobacter pylori<\/i> is not associated with the presence of the <i>cagA<\/i> gene"],"prefix":"10.1111","volume":"31","author":[{"given":"G.","family":"Bode","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Barth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.2.134"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.45.3.221"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02065547"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70394-X"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.5.1171"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1128\/JCM.37.7.2306-2311.1999","article-title":"Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes","volume":"37","author":"Van Dorn LJ","year":"1999","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.7.2274-2279.1999"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.12.5791"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.25.14648"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-77486-7_17"},{"key":"e_1_2_5_12_2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/iai.61.2.448-456.1993","article-title":"Comparison of Helicobacter pylori and attaching\u2010effacing Escherichia coli adhesion to eukaryotic cells","volume":"61","author":"Dytoc M","year":"1993","journal-title":"Infect Immun"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1995.tb07595.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(98)80041-8"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(99)00153-5"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.57.2.347-366.1993"},{"key":"e_1_2_5_17_2","first-page":"127","article-title":"Bacterial phospholipases","volume":"27","author":"Titball RW","year":"1998","journal-title":"Soc Appl Bacteriol Symp Ser"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0966-842x(97)01005-6"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(99)00205-1"},{"key":"e_1_2_5_20_2","first-page":"1383","article-title":"Cytolytic and phospholipase C activity in Legionella species","volume":"131","author":"Baine WB","year":"1985","journal-title":"J Gen Microbiol"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-0101(92)90469-L"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1997.68.4.369"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(11)80937-0"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/iai.63.1.94-98.1995","article-title":"Analysis of expression of cagA and vacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into major types and that CagA is not necessary for the expression of the vacuolating cytotoxin","volume":"63","author":"Xiang Z","year":"1995","journal-title":"Infect Immun"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90078-6"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01297087"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.5.588"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)91065-P"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9247463"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-139-12-3029"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-144-9-2505"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90341-W"},{"key":"e_1_2_5_33_2","first-page":"2111","article-title":"Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach","volume":"55","author":"Blaser MJ","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.1138_a.x"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.58.3.659-666.1990"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.10.945"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.4.442"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.6.804"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2001.00814.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2001.00814.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2362.2001.00814.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T17:18:05Z","timestamp":1697563085000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2362.2001.00814.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1046\/j.1365-2362.2001.00814.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2362.2001.00814.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}